Columbia University College of Physicians and Surgeons
Assistant Professor of Medicine, Director of Clinical Research, Columbia University Transplant Initiative
I have spent much of my career working to better understand how to treat hepatitis C virus infection in high risk populations, including before and after liver transplantation. I continue to be involved in these clinical trials as well as analyses of real world cohorts to better understand how and when to treat individual patients. In addition, I now have an NIH-funded research program to investigate the role of the intestinal microbiome in liver transplant outcomes.
What made you decide to work in transplantation?:
Liver transplantation is a very unique field that offers a broad array of clinical experiences. It is truly multidisciplinary, with integration of experience and expertise from team members with diverse backgrounds. Caring for patients with end stage organ failure and witnessing their recovery to health after transplant provides continuous inspiration and motivation. Although great strides have been made in the last several decades, as a clinical researcher, it is also clear that ongoing work is needed to improve the lives of patients with decompensated cirrhosis or post-transplantation complications.
What do you find to be the most valuable aspect of your work?:
Transplantation offers the ideal combination of advanced clinical care, ongoing education of trainees at all levels, and motivation to improve outcomes though clinical, translational and basic investigation.